Transfusion-dependent Thalassemia

• FDA approval · 2019-11-20
  FDA Approved: DEFERASIROX — Original Application (Dr. Reddy's Laboratories Inc)

  FDA approved Dr. Reddy's Laboratories' original application for deferasirox, a generic iron chelator used to treat chronic iron overload in …

• FDA approval · 2019-07-25
  FDA Approved: FERRIPROX — Supplemental Application (Chiesi USA, Inc.)

  The FDA approved a supplemental application for Ferriprox (deferiprone) submitted by Chiesi USA, Inc., updating/expanding the product's labe…

• FDA approval ·
  FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease

  FDA approves Casgevy (exagamglogene autotemcel) as a gene therapy for young children aged 2 years and older with sickle cell disease and rec…